← Back to Clinical Trials
Recruiting NCT07346742

NCT07346742 Prevention of Surgical Site Infection in Open Paediatric Groin Surgeries Using Intravenous Prophylactic Antibiotics and Antimicrobial-coated Sutures

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07346742
Status Recruiting
Phase
Sponsor Olawumi Olajide
Condition Inguinal Hernia
Study Type INTERVENTIONAL
Enrollment 174 participants
Start Date 2025-03-09
Primary Completion 2026-02-27

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Antimicrobial-coated suturesIntravenous CefuroximePlacebo intravenous injection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 174 participants in total. It began in 2025-03-09 with a primary completion date of 2026-02-27.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if the use of prophylactic antibiotics and antimicrobial-coated sutures can prevent surgical site infection in children undergoing open groin surgeries. The main question it aims to answer is: • Does the use of intravenous prophylactic antibiotics or antimicrobial-coated sutures significantly reduce the occurrence of surgical site infection in children undergoing open groin surgeries? Researchers will compare no antibiotic use to the use of intravenous prophylactic antibiotics, or antimicrobial-coated sutures to see if the use of intravenous prophylactic antibiotics and antimicrobial-coated sutures significantly reduces the occurrence of surgical site infection following open groin surgeries in children. Participants will: * Undergo open groin surgery with either the use of intravenous prophylactic antibiotic or antimicrobial-coated sutures or without antibiotic use * Visit the clinic on postoperative days 5, 13 and 30 for review of the surgical wounds for any sign of infection.

Eligibility Criteria

Inclusion Criteria: * All patients with clinical conditions requiring daycase open groin surgery Exclusion Criteria: 1. Re-operations 2. Immunocompromised patients 3. Malnourished patients 4. Complicated groin pathologies e,g obstructed inguinal hernia 5. History of antibiotic usage in the last seven days

Contact & Investigator

Central Contact

Olawumi Olajide, M.B.Ch.B

✉ yejola1212@gmail.com

📞 +2348038696179

Frequently Asked Questions

Who can join the NCT07346742 clinical trial?

This trial is open to participants of all sexes, up to 15 Years, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07346742 currently recruiting?

Yes, NCT07346742 is actively recruiting participants. Contact the research team at yejola1212@gmail.com for enrollment information.

Where is the NCT07346742 trial being conducted?

This trial is being conducted at Ile-Ife, Nigeria.

Who is sponsoring the NCT07346742 clinical trial?

NCT07346742 is sponsored by Olawumi Olajide. The trial plans to enroll 174 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology